CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops a novel medical device to monitor multiple biomarkers related to obesity and type 2 diabetes. By integrating optics, microfluidics, and electrochemistry, it aims to provide a portable solution for managing chronic disorders through precise biomarker tracking.
Obesity is one of the most common and costly chronic disorder worldwide, and is a causal or a strong risk factor for several comorbidities, as type 2 diabetes (T2D), which is now reaching epidemic proportions.
To monitor multifactorial disorders such as obesity and T2D, clinical evidences from more than one energetic biomarker are crucial.
Current multiplexed systems present limited multiplicity capacities because they combine individual tests spatially separated from the others requiring comple…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, Badajoz
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Sweden, Stockholm
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Institut de Recerca Biomedica Catalunya Sud (IRBCatSud)
Spain, Tarragona
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
